{"title": "The New York Times: Moderna Vaccine Highly Effective in Adolescents, Company Says", "author": null, "url": "https://stanfordhealthcare.org/newsroom/news/shc-in-the-news/2021/coronavirus-moderna-vaccine-adolescents.html", "hostname": "stanfordhealthcare.org", "description": "Moderna said on Tuesday that its coronavirus vaccine, authorized only for use in adults, was powerfully effective in 12- to 17-year-olds. In a clinical trial of the vaccine in adolescents, there were no cases of symptomatic Covid-19 among fully vaccinated teens, the company reported in a news release. Yvonne Maldonado, MD, Stanford Medicine professor of pediatrics and chair of the Committee on Infectious Diseases for the American Academy of Pediatrics, provides comment.", "sitename": "Stanford Health Care", "date": "2021-05-25", "cleaned_text": "New to MyHealth? Manage Your Care From Anywhere. Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill. Stanford Health Care in the News May 25, 2021 Moderna said on Tuesday that its coronavirus vaccine, authorized only for use in adults, was powerfully effective in 12- to 17-year-olds. In a clinical trial of the vaccine in adolescents, there were no cases of symptomatic Covid-19 among fully vaccinated teens, the company reported in a news release. [Yvonne Maldonado, MD](https://profiles.stanford.edu/yvonne-maldonado), Stanford Medicine professor of pediatrics and chair of the Committee on Infectious Diseases for the American Academy of Pediatrics, provides comment. Novel Coronavirus (COVID-19) Resource Center Stanford Medicine continues to follow all protocols recommended by the Centers for Disease Control and Prevention (CDC) to keep our community safe and reduce the risk of exposure to COVID-19. Media "}